glp-1 compounded semaglutide (GLP-1) | Clinician-Prescribed Semaglutide for weight loss |

Succinic semialdehyde (4-oxobutanoate) acts as a suitable substrate analog` as this molecule only lacks the 3-hydroxy group of MSA (3-hydroxy-4-oxobutanoate) which could be added in silico

Both companies have requested the FDA add semaglutide and tirzepatide, respectively, to its lists of drug products that present demonstrable difficulties for compounding. These DDC Lists identify substances that are considered particularly risky to compound, and drugs on these lists cannot be compounded under either 503A or 503B which could be the biggest problem for companies like Hims

It does not guarantee individual outcomes, clinician approval, or specific results

Saxenda can cost more than $1,800 per monthly prescription, but you can save almost $600 using a SingleCare prescription discount card

Are you using a GLP-1 receptor agonist? Listen closely

This effect reduces appetite and supports weight loss, making them increasingly popular beyond diabetes treatment